SynthesisBMC infectious diseases2025
The association between disclosure and antiretroviral therapy among adults living with HIV in China: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Obstetric Mistreatment Among Women Living With HIV.Nursing & health sciences · 2026Pooled it
- Disclosure and peer support in prevention of mother-to-child transmission of human immunodeficiency virus: Evidence from Rwanda.World journal of virology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAntiretroviral therapy (ART) and ART adherence are crucial for preventing HIV transmission and prolonging the lifespan of people living with HIV (PLWH). Serostatus disclosure is a significant factor influencing both ART initiation and ART adherence. However, studies evaluating the impact of disclosure on ART initiation and ART adherence in mainland China have yielded inconsistent findings. This systematic review and meta-analysis aim to examine the associations between disclosure and both ART initiation and adherence.
methodsWe systematically reviewed English databases (MEDLINE, Embase, Web of Science and the Cochrane Library) and Chinese databases (CNKI, WanFang, CQVIP, and SinoMed) to identify literature on factors that influence ART initiation and ART adherence from inception to Sep 24, 2024. Microsoft Excel 2019 sheet was used for data extraction. The data extraction sheet included information on the author's names, publication year of the study, study design, study population, sample size, definition of adherence to ART, and study quality score. The Joanna Briggs Institute (JBI) critical appraisal checklist for prevalence studies was employed to assess the quality of the selected articles. Data were analyzed using STATA 17.0, and a random effects model was utilized to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Sensitivity analyses were conducted through the sequential exclusion of studies. Publication bias was assessed using Begg's test and Egger's test.
resultsOur search yielded 517 results, of which 21 were eligible and included in the final meta-analysis. The analysis found that PLWH who disclosed their HIV serostatus were 2.59 times more likely to initiate ART compared to those who did not disclose (OR = 2.59, 95%CI: 1.92-3.49). However, we found no statistically significant association between HIV serostatus disclosure and ART adherence (OR = 1.21, 95%CI: 0.89-1.65). Additionally, no significant associations were identified between HIV serostatus disclosure and ART adherence in any subgroup analyses based on the subjects of disclosure, participants, or adjusted effect estimates for confounding factors.
conclusionsWe found evidence that serostatus disclosure is likely to positively associated with ART initiation, but not with ART adherence. Encouraging serostatus disclosure among PLWH, while simultaneously increasing public awareness about HIV and fostering a supportive environment for disclosure, may enhance ART adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.